311 W. SUPERIOR STREET, CHICAGO, IL
Leading the Next Frontier in Precision Cardiovascular Medicine 2026 NASDAQ: 1
Annual Meeting of Stockholders Held; Voting Results Disclosed
Annual Report to Security Holders
News
Announces 1-for-30 Reverse Stock Split
Revolutionizing Cardiovascular Medicine With Epigenetics and AI
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Submission Upload
Correspondence